Oncolytics Provides Update on Pancreatic Cancer Program for

/PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (Oncolytics) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, provided an...

Related Keywords

Canada , Canadian , Timothy Mccarthy , Jon Patton , Julie Fleshman , Matt Coffey , Clinical Group , Company Contact , Oncolytics Biotech Inc , Securities Exchange , Nasdaq , Pancreatic Cancer Action Network Pan , Esm Program , Oncolytics Biotech , Pancreatic Cancer Action Network , Precision Promise , Therapeutic Accelerator Award , Chief Executive Officer , Therapeutic Accelerator Award Grant , Securities Exchange Act ,